From the The PET/CT Center, Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China.
Department of Orthopedics, the People's Hospital of Chengdu Tianfu New Area, Chengdu, Sichuan, China.
Clin Nucl Med. 2022 Jan 1;47(1):e49-e51. doi: 10.1097/RLU.0000000000003863.
A middle-aged man was newly diagnosed with mucosa-associated lymphoid tissue lymphoma with secondary liver involvement. The hepatic lesion was not shown on FDG PET/CT but FAPI (fibroblast-activated protein inhibitor) PET/CT, which revealed abnormal FAPI accumulation. This case demonstrated that FAPI PET/CT might provide value in hepatic mucosa-associated lymphoid tissue lymphoma.
一名中年男性被新诊断为黏膜相关淋巴组织淋巴瘤伴肝继发受累。FDG PET/CT 未显示肝脏病变，但 FAPI（成纤维细胞激活蛋白抑制剂）PET/CT 显示异常 FAPI 聚集。本病例表明 FAPI PET/CT 可能对肝黏膜相关淋巴组织淋巴瘤具有一定价值。
